BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
Topic

Oxford University

14th edition of LLF to begin today

14th edition of LLF to begin today

Updated 06 Feb, 2026 08:18am
LAHORE: The three-day 14th edition of the Lahore Literary Festival (LLF) is set to commence on Friday (Today), 06...
BOP hosts Prof Stefan Dercon

BOP hosts Prof Stefan Dercon

Updated 02 Aug, 2024 07:52am
LAHORE: The Bank of Punjab Management held a client event in Lahore this week with Professor Stefan Dercon as Chief...
Prof Stefan calls on Dr Shamshad

Prof Stefan calls on Dr Shamshad

Published 23 Sep, 2023 05:58am
ISLAMABAD: Stefan Dercon, Professor of Economic Policy at Oxford University, Economics Department and former Chief...
Key insights from US trial data on AstraZeneca's COVID-19 vaccine

Key insights from US trial data on AstraZeneca's COVID-19 vaccine

Published 22 Mar, 2021 06:19pm
  • The trial results, primarily generated in the United States but also in Chile and Peru, included a 79% efficacy in preventing symptomatic COVID-19, and showed no increased risk of a rare form of blood clots that has caused concern in parts of Europe.
  • Britain's Medicines and Healthcare products Regulatory Agency concluded at the time that a 12-week gap between doses was the key to achieving the highest efficacy, of around 80%.
Malala signs Apple TV deal

Malala signs Apple TV deal

Updated 10 Mar, 2021 09:48am
ISLAMABAD: Pakistani activist Malala Yousafzai, who won the Nobel Peace Prize as a teenager after surviving a ...
UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly

UK regulators say extra AstraZeneca vaccine data highlights efficacy in elderly

Published 05 Feb, 2021 06:21pm
  • Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December.
  • Nevertheless, there was no evidence there, suggesting that those people over 65 were not getting evidence of efficacy.
Loading...